Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Yusufi FNK; Department of Statistics and Operations Research, Faculty of Science, Aligarh Muslim University, Aligarh, UP, 202002, India.; Ahmed A
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Insulins*; Adolescent
-
Source:
Endocrine, metabolic & immune disorders drug targets [Endocr Metab Immune Disord Drug Targets] 2023; Vol. 23 (5), pp. 609-616.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101269157 Publication Model: Print
Record details
-
Authors :
Yaribeygi H; Chronic Kidney Disease Research Center, Semnan University of Medical Sciences, Semnan, Iran.; Maleki M
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy
-
Source:
Current medicinal chemistry [Curr Med Chem] 2023; Vol. 30 (25), pp. 2850-2863.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9440157 Publication Model: Print
Record details
-
Authors :
Cui H; Department of Pharmacology, School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.; School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, TAS 7001, Australia.
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology
-
Source:
Current drug targets [Curr Drug Targets] 2023; Vol. 24 (8), pp. 648-661.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 100960531 Publication Model: Print
Record details
-
Authors :
Hoq MI; School of Public Health, Epidemiology, and Social Medicine, Institute of Medicine, University of Gothenburg, S-405 30 Gothenburg, Sweden.; Department of Public Health, University of Creative Technology Chittagong, Chittagong 4212, Bangladesh.
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Hypertension*/Hypertension*/Hypertension*/epidemiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology
-
Source:
Current diabetes reviews [Curr Diabetes Rev] 2023; Vol. 19 (6), pp. e290422204250.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101253260 Publication Model: Print
Record details
-
Authors :
Sadeghi M; Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Subjects: Diabetes Mellitus, Type 1* ; Diabetes Mellitus, Type 2*; Humans
-
Source:
Current medicinal chemistry [Curr Med Chem] 2023; Vol. 30 (14), pp. 1623-1637.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9440157 Publication Model: Print
Record details
-
Authors :
Wee AS; School of Pharmacy, Monash University Malaysia, Bandar Sunway, 47500, Selangor, Malaysia.; Faculty of Medicine, SEGi University, Kota Damansara, 47810 Selangor, Malaysia.
Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/etiology ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications
-
Source:
Current neuropharmacology [Curr Neuropharmacol] 2023; Vol. 21 (10), pp. 2036-2048.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101157239 Publication Model: Print
Record details
-
Authors :
Tagde P; Bhabha Pharmacy Research Institute, Bhabha University, Bhopal, M.P, India.; PRISAL Foundation (Pharmaceutical Royal International Society), Bhopal, M.P, India.
Subjects: Cardiovascular Diseases* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/prevention & control
-
Source:
Current diabetes reviews [Curr Diabetes Rev] 2022; Vol. 18 (9), pp. e131221198789.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101253260 Publication Model: Print
Record details
